The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCAR-T 2019 | Day 1 round up: CAR T-cell products
John Gribben, MD, DSc, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, chairs the day 1 round up of the 1st International Workshop on CAR-T (iwCAR-T), held in Miami, FL, along with Noelle Frey, MD, University of Pennsylvania, Philadelphia, PA, and David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA. Hear their thoughts on differences among CAR T-cell products, ethical issues in clinical trials, and product collection and manufacturing.
